AudiologyOnline Phone: 800-753-2160


Oticon Medical Ponto 5 Family - April 2022

ADHD and Kids: What is going on?

ADHD and Kids: What is going on?
Max Stanley Chartrand, PhD, BC-HIS
September 22, 2003
Share:
Editor's note: Although we don't usually publish ''op-ed'' material, this article presents compelling and important information, and I believe it is beneficial for all of us who work with, have, or were once were children! Please send your thoughts to me on this topic. We'll consider all responsible opinions for publication. Thanks! ---Douglas Beck, Editor-In-Chief.

Introduction:

With school starting again, I'd like to address a serious health issue that has been a long-standing interest of mine. This fall, more than 7 million American school-aged children1,2, or about 1 in 12, will be placed on a stimulant, similar to ''speed.'' Ritalin or its chemical variants are used to treat Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a non-clinical condition that many of us in the cognitive/communicative research community consider to be a somewhat contrived epidemic.

Just 20 years ago there were less than a half-million children placed on these powerful and potentially dangerous drugs. But between 1990 to 1997 there has been a 700% increase in the use of Ritalin et al3, and the rate continues today unabated. The United States, with only 5% of the world's population, consumes more than 85% of such medications4.To me, this state of affairs appears out of control!

Perhaps at the heart of this ''epidemic'' is the alliance between the U. S. Department of Education (DOE) and certain pharmaceutical companies5. It appears that billions of federal taxpayer dollars are dangled in front of cash-starved public schools, complete with slick video tape and print materials and workshops, to help the schools find, identify and treat as many children as possible. So aggressive has been the campaign to force this form of treatment and non-clinical diagnosis on parents and the public school system, that already 13 states have passed laws forbidding its recommendation.

In the meantime, more and more, medical doctors who previously resisted doing so have begun ''diagnosing'' without benefit of clinical tests or identifiable physical markers, and giving out prescriptions for powerful drugs like Ritalin, Wellbutrin, Effexor, and Desipramine. These are Class II narcotics ranked with opium, cocaine, morphine, and codeine6. Side effects can include; anxiety (for which anti-anxiety medication is often given), insomnia (sleeping pills for this), kidney failure, enlarged heart, seizures, addictive personality, and even death7.

What are the most common signs and symptoms of ADHD? A child who:
  • fidgets and squirms when bored

  • drinks Coca Cola (or caffienated anything, including chocolate, coffee, and takes certain pain medications)

  • suffers from undiagnosed food allergy

  • has a high-sugar (or no) breakfast before school

  • doesn't pay attention to the teacher
These, and many more children with explainable underlying psychosocial and nutritional influences stand a near absolute chance of being diagnosed with ADHD. In fact, one might say kids who are ''diagnosed'' with ADHD act like....well, boys8,9, 10,11. Hence, between 75-92% of children placed on ADHD medication are boys in the U.S. today. When we teach in-service training at some school districts we find some schools with no girls in their ADHD program! In others, only a handful. Why is that?

It could be due to the fact that the corpus collosum (the portion of the brain that allows the two hemispheres to talk to each other) tends to be about 30% smaller in young boys than in girls12,13,14. The theory behind our understanding of this neurological differential is that it contributes to gender specification in the development of the brain and body. From this, boys generally develop superior spatial, visual, and gross total body motor skills. Girls tend to develop superior communicative, social, fine-motor skills, and early cognitive development10.

An underdeveloped or developmentally delayed corpus collosum (CC) can cause a wide variety of learning and mental disabilities, including autism (it's higher form is known as Asperger's), dyslexia, stuttering, central auditory function, language delay, ADHD and interhemispheric discontinuity. These conditions are found overwhelmingly in young boys15,16,17,18,14, which in most cases tend to outgrow them during the maturation process.

But there's more: It must be noted that at any given time, 35% of children under the age of three in the U.S. suffer from otitis media with effusion (OME), a type of ear infection that plugs the auditory pathway in the middle ear, and causes speech, learning and cognitive developmental delays if left untreated long enough19, 20. It usually presents without pain or fever, so mom is often unaware of most episodes of OME; just the few that cause pain, discomfort and fever21.

Statistically, OME strikes girls about as often as boys. It is caused most often by inhalant allergy, which is increasing in our population, but often in food allergy, especially sugar20,22,23. The widespread and government-inspired practice of adding toxic levels of iron supplementation to baby formulae has caused untold misery for these kids, especially boys, who more readily suffer from iron toxicity than girls24,25,26.

And since boys' CC typically develops later than girls', boys statistically suffer many times more learning and communicative disabilities as a result of chronic OME than girls. Some say it is part and parcel of gender traits for boys to have more attentional and behavioral challenges during their early years, which if not responded to appropriately can later turn into real behavioral and attitude problems designed to cover seriously lagging academic skills.27

Hence, the rate of school dropouts is disproportionately high in the ADHD and OME groups, which comprise the largest segment of the juvenile justice population, and later, adults in prison. 96% of U.S. inmates today are male. Between 79% and 90% are functionally illiterate28,29,30.

So, the problem is real. But it is not...I repeat, it is not a pharmaceutical problem in the vast majority of cases. Treatment for real causes is needed, and there will be variations from child to child. Perhaps a tiny segment of these children can benefit from Ritalin and other drugs. Others may stem from abuse (especially domestic violence) and neglect. But to ignore a huge array of other causes, for which OME-inspired developmental delay leads the list, is arguably both misguided social engineering and possibly medical malpractice2.

In more than two decades of research on this problem, we have found a host of solutions for the current dilemma:

  • Early treatment for allergies and other underlying causes of OME

  • Auditory treatment and training, especially for central auditory disorder

  • Speech therapy and related treatment

  • Development of musical skills (piano lessons is best)

  • Avoidance of high sugar, caffeine drinks

  • Adequate time for restful sleep

  • High protein, low carbohydrate breakfast before school


  • Some of these are discussed on our consumer-education website https://www.digicare.org/. There are many other resources for parents and educators from which to draw additional information, some cited in the references section of this article.

    I realize this information is alarming. I fear we may be throwing out the baby with the bath water, and missing the forest for the trees in the rush for a quick and easy solution. I believe that common sense needs to prevail, and hope to see more of it applied in cases of ADHD!

    Dr. Chartrand serves as Director of Research for DigiCare Hearing Research & Rehabilitation, Rye, Colorado, and is a prominent author and lecturer in the hearing health field. Correspondence: https://www.digicare.org/ or fax to (719)676-6882.

    References:

    1. Baughman, F.A., Jr., Attention Deficit Hyperactivity Disorder, https://www.adhdfraud.com/, (2003)

    2. Baughman, F.A., Jr., Malpractice and Violation of Informed Consent, Citizens Commission on Human Rights, (2003)

    3. Holland, R., ''Classroom addiction to drug use'', The Washington Times, pg. A19, 17June(1999).

    4. Montandon, J.B., and Medioni, L., Evolution of the number of prescriptions of Ritalin (Methylphenidate) in the Canton of Neuchatel between 1996-2000, Pharmaceutical Control and Authorization Division, Switzerland, (2001).

    5. Rodie, D., ''ADHD: The New World Disorder'', Holland: Kleintje Muurkrant, March, (2001).

    6. National Institutes of Health Consensus Development Conference Statement: ''Diagnosis and Treatment of Attention Deficit/Hyperactivity Disorder ADHD,'' Journal of the American Academy of Child and Adolescent Psychiatry, 1 February, Pg. 23, (2000).

    7. Vastig, B., ''Pay Attention: Ritalin Acts Much Like Cocaine,'' Journal of the American Medical Association, August 22/29, Vol. 286, No. 8, pg. 905, (2001).

    8. www.ncjrs.org/html/ojjdp/jjbul19712-2/jjb1297f.html, Examining How Well Boys Fit Into the Proposed Pathways'', (2003).

    9. Beiderman, J., Mick, E., Faraone, S., et al, ''Infuence of Gender on Attention Deficit Hyperactivity Disorder in Children Referred to a Psychiatric Clinic'', Am J Psychiatry 159:36-42, January (2002).

    10. Chartrand, M.S., ''The Gender Factor'', Hearing Health, September/October, pp. 16-18, (1995).

    11. Chartrand, M.S., Hearing Instrument Counseling: Practical Applications for Counseling the Hearing Impaired, Livonia, MI: International Institutes for Hearing Instruments Studies, pp. 49-78, (1999).

    12. Bermudez, P., and Zatorre, R.J., ''Sexual Dimorphism in the Corpus Callosum: Methodological Considerations in MRI Morphometry'', NeuroImage, 13, pp. 1121-1130 (2001).

    13. Calvin, W.H., and Ojemann, G.A., Conversations with Neil's Brain: The Neural Nature of Thought and Language, Addison-Wessely, (1994).

    14. Harris-Schmidt, G., ''What are the Characterisitics of ADHD and ADD in Persons with Fragile X Syndrome?'', The National Fragile X Foundation, https://www.nfxf.org/, (2003).

    15. Hardman, M.L., Drew, C.J., Egan, M.W., Wolf, B., Human Exceptionality: Society, School, and Family, 4th edition, Boston:Allyn and Bacon, (1993).

    16. Hellige, J.B., Hemispheric Asymmetry: What's Right and What's Left, Cambridge, MA:Harvard University Press, (1993).

    17. Smith, C., and Strick, L., Learning Disabilities: A to Z, New York: The Free Press, Simon & Schuster, Inc., (1997).

    18. Biddulph, S., Raising Boys, Sydney:Finch Publishing, (1998).

    19. American Academy of Audiology, ''Identification of Hearing Loss & Middle Ear Dysfunction in Preschool & School-Age Children'', Academy Documents, https://www.audiology.org/Pages/default.aspx, (2003).

    20. Crook, W.G., ''Yeast, ADHD and Ear Infections'', Healthwell, https://www.healthwell.com/, (2003).

    21. https://www.drgreene.com/, ''Otitis Media with Effusion'', A-Z Guide, (2003).

    22. Randolph, T.G., ''Corn sugar as an allergen'', Annals of Allergy, 7:651-661, (1949).

    23. Kaplan, B.J., et al, ''Dietary replacement in pre-school-aged hyperactive boys'', Pediatrics, 83:7, (1989).

    24. Blanco, K., ''Iron Overload and Autism'', Med Hypotheses, August, (2003).

    25. Schwartz, S., ''Choosing the Right Infant Formula for Your Baby'', Childbirth Solutions, Inc., (2003).

    26. Sullivan, J.L., ''Stored Iron and Ischemic Heart Disease'', Circulation, 86:1036, (1992).

    27. Chartrand, M.S., and Chartrand, G.A., ''A Cognitive Primer for Parents'', Hearing Library, https://www.digicare.org/, (2002).

    28. Weber, W., Illiteracy Problems in America, https://www.csupomona.edu/, (1998).

    29. Meenan, A.L., and Burns, P.E., Adult Literacy and Technology Conference Proceedings, University Park, PA, (1987).

    30. Dalgish, C., ''Illiteracy and the Offender'', Adult Education, London, v56 n1, pp. 23-26, (1983).

    Rexton Reach - April 2024

    Max Stanley Chartrand, PhD, BC-HIS

    Director of Research

    Max Stanley Chartrand serves as Director of Research at DigiCare Hearing Research & Rehabilitation, Rye, CO, and has served in various capacities in research and development and marketing in the hearing aid and cochlear implant industry for almost 3 decades. He has published widely on topics of hearing health and is the 1994 recipient of the Joel S. Wernick Excellent in Education Award. He is currently working in the Behavioral Medicine doctoral program at Northcentral University. Contact: chartrandmax@aol.com or www.digicare.org.



    Related Courses

    Giving Children a Voice in Their Hearing Care Appointments: Using Ida Institute’s My Hearing Explained for Children in Your Daily Practice
    Presented by Natalie Comas, BSpPath, LSLS Cert. AVT
    Recorded Webinar
    Course: #37407Level: Introductory1 Hour
    How can pediatric hearing care professionals meet the challenge to support the 1989 United Nations “Convention on the Rights of the Child” rights in a family-respectful way? What are the benefits of following the principles of a new model of child-centered care and tools to ensure that children are at the center of hearing care? In this session, we will introduce a conversation guide, My Hearing Explained for Children. My Hearing Explained for Children is a free pediatric tool that helps hearing care professionals empower children and their families to make informed decisions about their hearing care.

    Hearing Loss in cCMV, in partnership with Midwestern University and Phoenix Children's Hospital
    Presented by Nathan Page, MD, Aditi Bhuskute, MD
    Recorded Webinar
    Course: #38714Level: Advanced1 Hour
    Hearing loss in cCMV has unique features, presentation, and long-term outcomes. This presentation highlights these unique features, and outlines the current evidence that guides identification and treatment of patients with this condition.

    Congenital Cytomegalovirus (cCMV): What Health Care Providers Need to Know Now, in partnership with Midwestern University and Phoenix Children’s Hospital
    Presented by Kathleen Muldoon, PhD, Nathan Page, MD, Aditi Bhuskute, MD, Stephanie Browning McVicar, AuD, CCC-A, Stephen L Pedron, MD, MBA, Deborah Flynn, AuD, Alissa Nickerson, AuD, Wendy Steuerwald, AuD, Harold Magalnick, MD, FAAP, Mimi Pruniski, OTR/L, Patrice Jung, MA
    Recorded Webinar
    Course: #38771Level: Advanced7 Hours
    The congenital CMV (cCMV) series presents the latest research on diagnosis and treatment, raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies infected with cCMV.

    Assessing Auditory Functional Performance: Goals and Intervention Considerations for Individuals with Hearing Loss
    Presented by Susan G. Allen, MED, CED, MEd, CCC-SLP, LSLS Cert. AVEd
    Recorded Webinar
    Course: #33024Level: Intermediate1 Hour
    Functional auditory assessment and continuing assessment is critical in order to determine the current level of function, develop appropriate goals for intervention, and achieve maximum outcomes. Learning to listen drives everything else: speech intelligibility, language competence, reading, academics, and life-long learning. This course offers a detailed look at functional auditory assessment and intervention, to provide audiologists with a better understanding of hearing loss in children in terms of the broader speech, language, learning and academic contexts. Additional videos to demonstrate key points will be included.

    Implementation of Cochlear Implants: Enhanced Candidacy Criteria and Technology Advances
    Presented by J. Thomas Roland, MD Jr.
    Recorded Webinar
    Course: #37377Level: Intermediate1 Hour
    The participant in this course will understand the extended candidacy criteria with cochlear implantation and expectations. The course will cover implanting under age one, hybrid hearing with cochlear implantation, CI under local anesthesia, single-sided deafness, cochlear implantation, and auditory brainstem implantation.

    Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.